gastrointestinal drugs market
Pharmaceuticals

Take Up Gastrointestinal Drugs Market Opportunities with Clear Industry Data – Includes Gastrointestinal Drugs Market Growth

Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!

 

Major players in the gastrointestinal drugs market include Sanofi, Bayer AG, Pfizer Inc., GlaxoSmithKline plc, The Procter & Gamble Company.

 

TBRC’s comprehensive market report based on extensive research will assist you in seamlessly devising your approaches in order to match key market player strategies.

 

The gastrointestinal drugs market is expected to reach $62.19 billion in 2025 at a rate of 5.9%. The gastrointestinal drugs market is then expected to grow at a CAGR of 5.1% from 2025 and reach $79.87 billion in 2030 period.

 

North America was the largest region in the global gastrointestinal drugs market.

 

The gastrointestinal drugs market consists of sales of gastrointestinal drugs by entities (organizations, sole traders and partnerships) that are engaged in manufacturing gastrointestinal drugs to treat gastrointestinal diseases such as ulcerative colitis, diverticular disease, perianal infections, anal fissures, hemorrhoids, constipation, and irritable bowel syndrome.

 

The gastrointestinal drugs market is expected to drive the new emerging drug delivery methods.

 

Request a Sample of the Gastrointestinal Drugs Market Report

 

Gastrointestinal drugs manufacturers are using floating drug delivery systems for the treatment of local infections related to the gastrointestinal tract. The bilayer floating tablet is the core component of the floating drug delivery system (FDDS), which is used to extend the gastric residence time in the stomach. It’s best for treating local infections including peptic ulcers, gastritis, Zollinger-Ellison syndrome, indigestion, and other gastrointestinal tract infections, but it can also be used for systemic infections. Drugs that are acid labile and have a short half-life benefited from FDDS protection. It also increases drug bioavailability, decreases drug waste, and extends drug residence duration. Various technologies are now being employed in the development of FDDS. The inclusion of novel drug delivery technologies into bilayer floating tablets has also expanded the usefulness of FDDS. Polymers play a key role in the creation of FDDS because they serve as drug carriers and determine gastric retention time and drug protection. FDDS is also a simple, inexpensive, and more convenient form of dual medication delivery.

 

TBRC’s Gastrointestinal Drugs Market Report Is Segments:
By Type: Antacids, Antiulcerants, Antiemetics and Antinauseants, Antidiarrhoeals, others

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others

By Route of Administration: Oral, Parenteral

By Drug Classification: Branded Drugs, Generic Drugs

By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

By Geography: North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

 

The Gastrointestinal Drugs Market Report 2022 –Opportunities And Strategies – Global Forecast To 2030 is one of a series of new reports from The Business Research Company that provides an overview of the gastrointestinal drugs market globally and regionally, analyzes and forecasts market size, share, gastrointestinal drugs market players, gastrointestinal drugs market segments, leading competitor revenues, profiles and market shares.

 

Here Is A List Of Similar Reports From The Business Research Company:

Healthcare Specialty Enzymes Market 2022

Digestive Health Supplements Global Market Report 2022

Healthcare Specialty Enzymes Market 2022

 

Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

 

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

 

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow us on LinkedIn:  https://in.linkedin.com/company/the-business-research-company

Follow us on Twitter:  https://twitter.com/tbrc_info

Check out our Global Market Model:  https://www.thebusinessresearchcompany.com/global-market-model

 

Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *